EG Rosuvastatina e Ezetimibe

Rosuvastatina e Ezetimibe EG is a combination pharmaceutical product used to treat high cholesterol. The 'EG' branding stands for EuroGenerici, an Italian pharmaceutical company founded in 1996 in Milan. EuroGenerici was established to introduce generic medicines to the Italian market, promoting more affordable healthcare options.

In 1999, EuroGenerici was acquired by the STADA Group (STADA Arzneimittel AG), a prominent German pharmaceutical manufacturer headquartered in Bad Vilbel. Today, the brand operates as the Italian subsidiary of the STADA Group. While the brand is Italian by origin, the manufacturing of its various generic products occurs across a global network of STADA-owned facilities or specialized third-party manufacturers, typically located in Europe or India, depending on the specific formulation.